The MAGiC™ Cardiac Ablation European Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.

Also called NCT06019845

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
  • Stereotaxis Registry lists this organization as the lead sponsor
Registry
  • NCT NCT06019845
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Denmark, Lithuania, Netherlands, Poland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06019845. Allocation not applicable; no masking; primary purpose treatment. Start 2024-01-02 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The MAGiC™ Cardiac Ablation European Study
Acronym
MAGiC-FESTPMCF
Condition
Arrhythmias, Cardiac
Intervention (Device)
MAGiC™
Lead sponsor
Stereotaxis (class: industry)
Collaborator
Osypka AG (class: not stated)

Record details

Record id
cardio:ct-nct06019845
Content hash
eec70943152a6c98c4c20492eed252eb64fc0fd3ea864980fe3564cd4e28a574